The marketing authorization is granted to Telix’s partner R2PHARMA, Brazil’s leading cold kit manufacturer, nuclear pharmacy and cyclotron network, and a subsidiary of GSH Corp Participações S.A.

A global pharmaceutical company, having recently acquired a mid-cap biotech firm, sought to evaluate the market value of a newly obtained oncology asset. The drug, part of an emerging class of immune ...